Expression Table for this CRE
| SRX7078888 | IPMN cell lines derived from mouse models of pancreatic cancer: Ptf1a-Cre; KrasG12D; Brg1f/f PDA | 849.0 |
| CNhs12670 | J2E erythroblastic leukemia response to erythropoietin, 00hr30min, biol_rep2 | 784.2 |
| CNhs12651 | J2E erythroblastic leukemia response to erythropoietin, 02hr30min, biol_rep1 | 771.9 |
| CNhs12668 | J2E erythroblastic leukemia response to erythropoietin, 00hr00min, biol_rep2 | 710.5 |
| CNhs12650 | J2E erythroblastic leukemia response to erythropoietin, 02hr00min, biol_rep1 | 691.8 |
| SRX690749 | WT liver male etiology/histology:WT | 656.8 |
| SRX4504817 | mouse NET-CAGE kidney samples, biol_rep2 | 625.7 |
| SRX4504814 | mouse NET-CAGE kidney samples, biol_rep1 | 625.7 |
| SRX690748 | WT liver male etiology/histology:WT | 623.2 |
| SRX690755 | Mdr2-KO liver male etiology/histology:Inflammation | 617.5 |
| SRX690754 | Mdr2-KO liver male etiology/histology:Inflammation | 602.4 |
| CNhs12669 | J2E erythroblastic leukemia response to erythropoietin, 00hr15min, biol_rep2 | 593.7 |
| SRX690757 | Mdr2-KO liver female etiology/histology:40% AD, 0% HCC | 592.4 |
| SRX4504811 | mouse NET-CAGE brain, biol_rep1 | 586.5 |
| SRX690756 | Mdr2-KO liver male etiology/histology:Inflammation | 569.7 |
| SRX690751 | WT liver male etiology/histology:WT | 565.2 |
| SRX690764 | Mdr2-KO liver male etiology/histology:60% AD, 10% HCC | 562.8 |
| CNhs12532 | Sox2+ Supporting cells - organ of corti, pool1 | 562.0 |
| SRX690752 | WT liver male etiology/histology:WT | 560.4 |
| SRX690753 | WT liver male etiology/histology:WT | 552.5 |
| SRX690765 | Mdr2-KO liver male etiology/histology:50% AD, 20% HCC | 549.1 |
| SRX690750 | WT liver male etiology/histology:WT | 548.3 |
| SRX690763 | Mdr2-KO liver female etiology/histology:10% AD, 20% HCC | 538.8 |
| SRX4504808 | mouse CAGE kidney samples, biol_rep2 | 523.5 |
| SRX690762 | Mdr2-KO liver male etiology/histology:70% AD, 10% HCC | 512.3 |
| SRX7078887 | PanIN cell lines derived from mouse models of pancreatic cancer: Ptf1a-Cre; KrasG12D; p53f/+ PDA | 491.4 |
| SRX4504805 | mouse CAGE kidney samples, biol_rep1 | 488.1 |
| SRX9816724 | nitric oxide unexposed lung tissue of wild type mice | 482.6 |
| SRX690772 | Mdr2-KO liver female etiology/histology:80% AD, 10% HCC | 480.7 |
| SRX690771 | Mdr2-KO liver female etiology/histology:80% AD, 10% HCC | 480.1 |
| SRX4504802 | mouse CAGE brain, biol_rep1 | 477.9 |
| SRX690773 | Mdr2-KO liver male etiology/histology:70% AD, 20% HCC | 474.5 |
| CNhs10468 | colon, adult | 466.0 |
| CNhs10473 | cortex, adult | 454.0 |
| SRX690770 | Mdr2-KO liver male etiology/histology:70% AD, 10% HCC | 453.5 |
| SRX8428120 | NR5A1-expressing pre-Sertoli cells in E11.5 gonads of C57BL/6 strain mouse: genotype Nr5a1-hCD271 | 450.5 |
| SRX690769 | Mdr2-KO liver male etiology/histology:70% AD, 30% HCC | 447.7 |
| CNhs10487 | corpus striatum, adult | 433.1 |
| SRX690760 | Mdr2-KO liver male etiology/histology:60% AD, 0% HCC | 422.1 |
| SRX690761 | Mdr2-KO liver male etiology/histology:70% AD, 20% HCC | 399.2 |
| SRX9816729 | nitric oxide unexposed lung tissue of triply n/i/eNOSs-/- mice | 398.9 |
| CNhs14360 | macrophage, TB infection, stimulated BMDM+IL-13(aaMph), with Mtb, 072hr(048h after stimulation), biol_rep4 | 392.8 |
| CNhs14361 | macrophage, TB infection, stimulated BMDM+IL-13(aaMph), with Mtb, 120hr(096h after stimulation), biol_rep4 | 391.8 |
| SRX690758 | Mdr2-KO liver male etiology/histology:30% AD, 0% HCC | 391.4 |
| SRX690767 | Mdr2-KO liver male etiology/histology:80% AD, 10% HCC | 387.8 |
| CNhs10476 | mammary gland, adult pregnant day19 | 385.2 |
| SRX690766 | Mdr2-KO liver female etiology/histology:30% AD, 40% HCC | 382.7 |
| SRX690759 | Mdr2-KO liver male etiology/histology:20% AD, 0% HCC | 382.7 |
| SRX690768 | Mdr2-KO liver male etiology/histology:80% AD, 20% HCC | 381.7 |
| SRX9816725 | nitric oxide unexposed lung tissue of wild type mice | 374.7 |